SBUX · News · 20260807N
Employee Health Benefit Changes
STARBUCKS CORP · 2026-08-07 · Importance 36 · Surprise 42 · In source text
Starbucks will stop covering GLP-1 drugs prescribed for weight loss for benefits-eligible employees in October 2026. The change reflects rising employer healthcare costs and the growing share of benefits spending consumed by GLP-1 medicines. The reported policy applies to weight-loss prescriptions rather than all GLP-1 treatments.
Key facts
- Starbucks will stop covering GLP-1 drugs prescribed for weight loss for benefits-eligible employees starting in October 2026. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | positive | committed | — | Starbucks will stop covering GLP-1 drugs prescribed for weight loss for benefits-eligible employees starting in October 2026. |